Skip to content

Huntsman HUN Proceeds From Derivative Instrument Investing Activities

Proceeds From Derivative Instrument Investing Activities at other companies

Global Business Travel Group logo
Global Business Travel GroupGBTG
$0-100%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$431K
Newell Brands logo
Newell BrandsNWL
$9M0.0%
KEE
Keel Infrastructure Corp. Common StockKEEL
$1.4M-95.1%
Bausch + Lomb logo
Bausch + LombBLCO
$5M-16.7%
CleanSpark logo
CleanSparkCLSK
$19.89M

Other financials

Income statement

See full
Revenue$1.4B+0.7%
Net income-$41.0M-473%

Balance sheet

See full
Cash & equivalents$369.0M+10.5%
Total debt$2.5B+5.6%
Total equity$2.7B-9.1%
Total assets$7.1B-1.4%

Cash flow

See full
Operating cash flow-$53.0M+28.4%
CapEx$38.0M+5.6%
Free cash flow-$91.0M+17.3%

Valuation

See full
Market cap$1.99B-15.6%

Profitability

See full
Gross margin16.8%
Operating margin2.5%
Net margin-4.9%-9.2pp
FCF margin2.4%+1.1pp

Returns & leverage

See full
Return on equity-9.9%-17.8pp
Debt / equity0.9×+0.1×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Huntsman in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities.

The official record: Huntsman’s 10-K, filed February 15, 2022, on SEC EDGAR. View the filing →

Ask your AI about Huntsman's proceeds from derivative instrument investing activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Huntsman's proceeds from derivative instrument investing activities?
Huntsman (HUN) reported proceeds from derivative instrument investing activities of $0 in Q4 2021.